Rapid antibody-based tests for COVID-19 hotspots first
Part of: GS Prelims and GS-II – Health
- According to The Indian Council of Medical Research (ICMR), the rapid antibody based blood test for COVID-19 will be deployed in clusters and hot spots showing high incidence of confirmed cases.
- Moreover, over all testing for COVID-19 using real-time reverse transcription polymerase chain reaction (RT-PCR) is also increasing.
- All States/UTs have been issued guidelines for implementing Rapid antibody – based tests.
- Reports shall be entered into the ICMR portal similar to results of real-time RT PCR tests for COVID-19.
Important value additions:
The Indian Council of Medical Research (ICMR)
- It is the apex body in India for the formulation, coordination and promotion of biomedical research.
- The ICMR is funded by the Government of India through the Department of Health Research, Ministry of Health.
Real-time reverse transcription polymerase chain reaction (RT-PCR)
- It is a laboratory technique combining reverse transcription of RNA into DNA.
- It detects the virus.
Rapid antibody – based test
- It uses blood.
- It detects the body’s response to the virus.
- A positive result tells that the body was exposed to the virus.
- It means testing samples from multiple patients with a single PCR test.
- It has been used previously in the early stages of the HIV epidemic.
- Such tests reduce the time, cost, and resources required.
- It identifies infected people in a population and estimates the infection rate.
- This allows medical experts to identify community clusters for targeted public health interventions.
IASbaba imparts 360-degree IAS preparation solutions with their exhaustive Prelims and Mains preparation courses, supported by the latest UPSC preparation material. Avail our expert help by enrolling with us to keep your knowledge updated and stay ahead of your competition.
Most Trending and Trusted Programmes by UPSC Toppers :